Last update 21 Nov 2024

CMD-EO05

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
Target-
Mechanism-
Therapeutic Areas
Neoplasms
Active Indication
EGFR mutation Solid TumorsSolid tumor
Inactive Indication-
Originator Organization
Zhejiang Shimai Pharmaceutical Co., Ltd.Zhejiang Shimai Pharmaceutical Co., Ltd.
Active Organization
Zhejiang Shimai Pharmaceutical Co., Ltd.Zhejiang Shimai Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with CMD-EO05
CTR20243706 / RecruitingPhase 1
一项评估CMDE005在EGFR阳性晚期实体瘤患者中安全性、药代动力学特征和有效性的单臂、开放性、多中心的I/IIa期临床研究
[Translation] A single-arm, open-label, multicenter Phase I/IIa clinical study to evaluate the safety, pharmacokinetic characteristics and efficacy of CMDE005 in patients with EGFR-positive advanced solid tumors
ChiCTR2400090635 / SuspendedPhase 1/2IIT
An Open-Label, Phase 1/2a, Single-Arm Study Assessing the Safety, Pharmacokinetics and Efficacy of CMDE005 in Patients with EGFR-Positive Advanced Solid Tumors
100 Clinical Results associated with CMD-EO05
Login to view more data
100 Translational Medicine associated with CMD-EO05
Login to view more data
100 Patents (Medical) associated with CMD-EO05
Login to view more data
100 Deals associated with CMD-EO05
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EGFR mutation Solid TumorsPhase 1
CN
Zhejiang Shimai Pharmaceutical Co., Ltd.Zhejiang Shimai Pharmaceutical Co., Ltd.
18 Oct 2024
Solid tumorPreclinical
CN
Zhejiang Shimai Pharmaceutical Co., Ltd.Zhejiang Shimai Pharmaceutical Co., Ltd.
12 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free